Zydus Lifesciences (ZYDUSLIFE) — Buyback / Redemption

1 Buyback / Redemption 🟡 Notable Neutral 📄 PDF

Zydus Lifesciences completed its acquisition of an 85.6% stake in Amplitude Surgical SA through its French subsidiary Zydus MedTech France, finalized on July 29, 2025. The company will launch a mandatory tender offer on July 30, 2025, targeting the remaining shares at €6.25 per share, aiming to exceed 90% ownership and initiate a squeeze-out. The offer is subject to French regulator approval and anticipated to open in September 2025.

2 Buyback / Redemption 🟡 Notable Neutral 📄 PDF

Zydus Lifesciences completed acquisition of 85.6% stake in Amplitude Surgical for €256 million at €6.25 per share on July 29, 2025. The company will file a simplified mandatory tender offer on July 30, 2025 for remaining shares at the same price. With 4.7% undertakings from seven shareholders, Zydus expects to secure over 90% ownership and pursue squeeze-out. AMF clearance anticipated for September 2025 opening.

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this buyback / redemption affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 29 July 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 29 July 2025

VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Financial Results VBL Varun Beverages Limited Corporate Action VBL Varun Beverages Limited Corporate Action VBL Varun Beverages Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.